# A Study of Ceftobiprole in Patients With Fever and Neutropenia.

> **NCT00529282** · PHASE3 · TERMINATED · sponsor: **Basilea Pharmaceutica** · enrollment: 2 (actual)

## Conditions studied

- Fever
- Neutropenia
- Gram-positive Bacterial Infections
- Pseudomonas Infection

## Interventions

- **DRUG:** Ceftobiprole Medocaril
- **DRUG:** Cefepime with or without vancomycin

## Key facts

- **NCT ID:** NCT00529282
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study discontinued due to administrative reasons unrelated to safety
- **Last updated:** 2012-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00529282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00529282, "A Study of Ceftobiprole in Patients With Fever and Neutropenia.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00529282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*